Episodes

  • Ketamine and the Matthew Perry Tragedy

    Ketamine and the Matthew Perry Tragedy
    Sep 30 2024
    In this episode, Dr. Dave Rabin and Dr. Jonathan Edwards tackle the controversial topic of ketamine in light of the tragic death of actor Matthew Perry. Together, they explore the safety profile of ketamine, its legitimate uses in treating depression and suicidal ideation, and dispel misinformation regarding its association with Perry's passing.Dr. Edwards, a leading expert in ketamine-assisted therapy and author of The Revolutionary Ketamine, offers his insights on the pressing need for effective mental health treatments. As suicide rates continue to rise, particularly among young people, this episode emphasizes the potential of ketamine as a life-saving treatment and the importance of therapy in conjunction with medication.Tune in to gain a deeper understanding of ketamine’s role in mental health and how it can potentially save lives.
    • The Revolutionary Ketamine on Amazon
    • Stopping Pain: A Revolutionary Approach on Amazon
    • Dr. Jonathan Edwards' Website
    • Subscribe to Dr. Edwards' Substack
    • Web: https://psychedelic.support/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    Show more Show less
    32 mins
  • Making the Good Vibes Last with Shawn Wells

    Making the Good Vibes Last with Shawn Wells
    Sep 11 2024
    How do we optimize our bodies and our brains for learning new things? In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes back nutritional biochemist Shawn Wells to explore the often-overlooked topic of post-psychedelic supplementation. They discuss how to optimize the benefits of psychedelic experiences and ensure that the transformations achieved during these journeys can last longer.
    Shawn shares his expertise on various supplements, nutrients, and dietary strategies that can enhance neuroplasticity, support mental health, and promote overall well-being after a psychedelic experience. The conversation covers essential topics such as hydration, the role of adaptogens, the importance of neurotransmitter repletion, and the impact of diet on recovery.
    Tune in for valuable insights from leading experts in the field of Psychedelic Medicine.

    Optimizing Psychedelic Medicine Experiences with Shawn Wells

    • Web: https://shawnwells.com/
    • Instagram: https://www.instagram.com/shawnwells
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com
    Show more Show less
    56 mins
  • The FDA Rejects MDMA-Assisted Therapy

    The FDA Rejects MDMA-Assisted Therapy
    Aug 28 2024
    In this episode, Dr. Dave Rabin discusses the impact of the FDA's decision, the potential delays in accessing this crucial treatment, and the unethical behavior of certain organizations influencing the FDA. Dr. Rabin is joined by Jon Lubecky, a retired army sergeant and Veteran who took part in MAPS MDMA therapy trials, as he discusses the implications of this rejection and emphasizes the need for ongoing advocacy and hope for eventual approval. The episode also addresses the unethical behavior of Symposia, an organization accused of falsifying information to the FDA to obstruct MDMA therapy approval. Additionally, former Symposia member David Nichols reveals serious ethical violations within the organization, raising questions about their motives and funding. Through these discussions, the episode highlights the critical need for transparency, ethical practices, and continued efforts to ensure access to psychedelic treatments for those in need.
    Rachel Nuwer’s Scientific American Article: https://www.scientificamerican.com/article/fdas-rejection-of-mdma-psychotherapy-for-trauma-draws-criticism-from/
    Jon Lubecky’s Conversation with David Nickles on Breaking Points: https://www.youtube.com/watch?v=lttFB0c0cAo
    • Web: https://psychedelic.support/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193
    Show more Show less
    41 mins
  • MDMA Therapy vs. PTSD: Which is Safer? Featuring Dr. John Miller MD

    MDMA Therapy vs. PTSD: Which is Safer? Featuring Dr. John Miller MD
    Aug 9 2024
    In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.

    John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.

    Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.

    Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.

    Brain Health in Exeter, New Hampshire (http://www.brain-health.co)
    Psychiatric Times (http://www.psychiatrictimes.com)
    https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    https://www.linkedin.com/in/jjmillermd/

    https://www.linkedin.com/company/psychiatric-times/

    www.apolloneuro.com

    FDA petition for MDMA-assisted therapy
    https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
    Show more Show less
    34 mins
  • Dispelling the False Claims about MAPS and MDMA-Assisted Therapy

    Dispelling the False Claims about MAPS and MDMA-Assisted Therapy
    Aug 5 2024
    In this episode, Dr. Dave Rabin MD, PhD is joined by Dr. Geoff Bathje PhD who authored an article published on July 19, 2024 in Chacruna entitled: “The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy.”Dr. Bathje and Dr. Rabin discuss the recent FDA Advisory Committee vote on MDMA-assisted therapy for PTSD, which surprisingly and wrongfully concluded that the benefits do not outweigh the risks. This conversation deep dives into Dr. Bathje’s report on how Psymposia, what appears to be a group of fringe radicals, negatively biased the FDA committee's vote on June 4 by writing letters with false and misleading claims in an attempt to prevent the clearance of MDMA for PTSD. Why would anyone not only want to prevent clearance of MDMA therapy for Veterans, but see themselves as heroes for doing so? Find out all that and more in this weeks episode of The Psychedelic Report.


    The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy by Dr. Geoff Bathje: https://chacruna.net/unbelievable-claims-of-psymposia-about-maps-and-mdma-assisted-therapy/
    • Web: https://psychedelic.support/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/

    FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
    Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193
    Show more Show less
    45 mins
  • MDMA Therapy and the FDA Advisory Committee’s Bias with Jesse Gould

    MDMA Therapy and the FDA Advisory Committee’s Bias with Jesse Gould
    Jul 25 2024
    In this episode of The Psychedelic Report, Jesse Gould, Veteran Army Ranger and Founder of the Heroic Hearts Project, joins Dr. Dave Rabin to explore the implications of the recent FDA advisory committee vote on MDMA-assisted therapy for Veterans with PTSD. They highlight concerns over the influence of non-objective groups on the committee's decision and discuss the potential impact on millions of individuals seeking effective treatment for mental health challenges.
    Join the conversation as they explore the implications of disrupting the progress of a groundbreaking treatment and the importance of advocating for evidence-based therapies. Learn how you can get involved and make your voice heard to support the advancement of MDMA-assisted therapy for those who need it most.
    To take action and stay informed, visit Heroic Hearts and sign up for updates on upcoming initiatives. Let's come together to ensure access to life-changing treatments for Veterans and individuals suffering from PTSD.
    Don't miss this insightful discussion on the intersection of medicine, advocacy, and the future of psychedelic therapies. Subscribe to The Psychedelic Report for more thought-provoking episodes on the latest developments in psychedelic medicine and healing.

    FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/

    Food and Drug Administration
    5630 Fishers Lane
    Rm. 1061
    Rockville, MD 20852
    Docket No. FDA-2024-N-193


    • Web: https://heroicheartsproject.org/our-story/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com
    Show more Show less
    51 mins
  • The Status of MDMA Therapy and the Veteran Impact

    The Status of MDMA Therapy and the Veteran Impact
    Jul 10 2024
    In this compelling episode of The Psychedelic Report, Dr. Dave Rabin delves into the evolving landscape of psychedelic-assisted therapies with special guest Jon Lubecki, a veteran and prominent advocate for such treatments in Ukraine. The discussion centers on the recent FDA advisory committee setback, which resulted in a 10 to 1 vote against MDMA-assisted therapy due to lingering concerns about its safety and efficacy, particularly in post-treatment activities like driving. Jon provides a nuanced analysis of the hearing, pointing out significant conflicts of interest among some opponents who failed to disclose their affiliations with competing therapies like psilocybin and ketamine. He also examines the critical role of influential organizations such as ICER and Symposia, whose biased reports have swayed public and regulatory opinions against MDMA trials. With a fervent focus on the broader implications for mental health, especially for veterans suffering from PTSD, Jon underscores the inadequacy of current treatments and the transformative potential of MDMA-assisted therapy. He shares his personal journey from struggling with PTSD to becoming a leading advocate, passionately calling for the democratization of access to these promising therapies, transcending political and social boundaries.
    • Instagram: https://www.instagram.com/jonathanlubecky/
    • Web: www.mdmaptsd.org
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com

    Congressman Dan Crenshaw speaks out on the MDMA-assisted therapy controversy and the anti-Veteran agenda :
    https://www.instagram.com/reel/C8zsu2Wu7M0/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==

    FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/

    Food and Drug Administration
    5630 Fishers Lane
    Rm. 1061
    Rockville, MD 20852
    Docket No. FDA-2024-N-193
    Show more Show less
    42 mins
  • The FDA, MDMA Therapy, and Tucker Max

    The FDA, MDMA Therapy, and Tucker Max
    Jun 24 2024
    In the latest episode of The Psychedelic Report, Dr. Dave Rabin shares the latest news on the MDMA-Assisted Therapy trials evaluation by the FDA Advisory Committee from June 4, who voted a surprising 10-1 that the risks of this breakthrough treatment outweigh the benefits. This was particularly astonishing to clinicians and researchers as described by Rachel Nuwer in her latest article in the BBC published on June 20. We’ll take a deep dive into this article and the discussion of safety and risks of MDMA-Assisted Therapy, followed by an enlightening conversation with award-winning author Tucker Max about his personal journey achieving a greater sense of safety with psychedelic-assisted therapy.


    Tucker discusses the importance of safety and integration practices in maximizing the benefits of psychedelic experiences. He emphasizes the role of journaling, psychotherapy, and lifestyle changes in supporting the integration process and facilitating personal growth. Tucker's journey highlights the profound impact of psychedelics on mental health, self-discovery, and relationships.
    Don't miss this insightful episode, where real-life experiences and expert perspectives converge to explore the healing potential of psychedelic medicines. Tune in now to embark on a journey of self-discovery and transformation with Tucker Max.


    Web: https://www.tuckermax.com/
    Twitter: https://twitter.com/DrDavidRabin
    Instagram: https://www.instagram.com/drdavidrabin
    Web: https://www.drdave.io/
    Web: www.ApolloNeuro.com


    Tucker’s Books: https://www.tuckermax.com/books/#:~:text=Tucker%20Max's%20first%20three%20books,success%20has%20meant%20his%20success.


    Article: FDA advisors voted against MDMA therapy – researchers are still fighting for it
    https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it


    Your Brain Explained Episode 1 - The MDMA Breakthrough: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=0377e20f02ed481d


    Rachel Nuwer’s NYT article breaking the study findings: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html


    Nature Medicine MDMA trial science article 1: https://www.nature.com/articles/s41591-021-01336-3


    Nature Medicine MDMA trial science article 2: https://www.nature.com/articles/s41591-023-02565-4


    Special episode of The Tim Ferriss Show with Dr. Dave Rabin on MDMA Therapy: https://open.spotify.com/show/5qSUyCrk9KR69lEiXbjwXM

    Food and Drug Administration
    5630 Fishers Lane
    Rm. 1061
    Rockville, MD 20852
    Docket No. FDA-2024-N-193
    Show more Show less
    47 mins